US manufacture SDIX manufactures all products in the USA and holds ISO13485:2016 certification, signaling strong quality and compliance for regulated immunoreagents and large-scale antibody production—a selling point for customers seeking domestic, quality-assured supply.

GMP capacity Specialization in high quality, large-scale GMP antibody production and in vitro monoclonal and polyclonal antibody services positions SDIX as a potential supplier for large-volume diagnostic and research programs requiring scalable, validated antibody production.

Contract manufacturing SDIX offers contract manufacturing across multiple species, suggesting opportunities to partner on custom antibody development and production for clients with diverse species requirements or niche immunoreagents.

Regulatory readiness ISO13485:2016 certification and GMP focus indicate strong regulatory and quality management capabilities, which can be leveraged to target customers in medical devices, diagnostics, and regulated research sectors seeking compliant supply chains.

Expansion signals Past strategic partnerships and divestiture history, along with a revenue range in the mid-market, imply potential for growth through new collaborations, OEM-type agreements, or expansion into complementary immunoassay components and calibrators.